Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience
Practical Radiation Oncology · 2024
DOI: 10.1016/j.prro.2023.12.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Practical Radiation Oncology, 2024. Verfasst von Brianna Conte und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of Miami Miller School of Medicine, Miami, Florida. Electronic address: bxc661@miami.edu. Hauptthemen laut MEDLINE: Neuroblastoma, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Comprehensive Cancer Network.
Abstract (Originalsprache)
PURPOSE: To evaluate outcomes after intraoperative radiation therapy (IORT) in high-risk neuroblastoma (NB), including local control, overall survival, and toxicity. METHODS AND MATERIALS: This was a single institution retrospective study of 92 pediatric patients with NB treated with IORT from 1995 to 2022. Each IORT application was considered a separate event for a total of 110 sites treated. Local failure was calculated using the cumulative incidence function and survival by Kaplan-Meier method from the day of surgery. RESULTS: All patients had high-risk relapsed or treatment refractory disease. Median age was 6 years (range, 2-34 years). Median follow-up for all patients and surviving patients was 16 months and 4 years, respectively. All patients previously received chemotherapy, 93% had prior external beam radiation therapy to the site of IORT (median dose, 21.6 Gy; range, 10-36 Gy), and 94% had a prior surgery for tumor resection. The median IORT dose was 12 Gy (range, 8-18 Gy) and median area treated was 18 cm2 (range, 2.5-60 cm2). The cumulative incidence of local failure was 23% at 2 years and 29% at 5 years. The overall survival (OS) was 44% at 2 years and 29% at 5 years. Local failure after IORT was associated with worse OS (hazard ratio, 1.74; 95% CI, 1.07-2.84; P = .0267). Toxicity from IORT was rare, with postoperative complications likely related to IORT seen in 7 (8%) patients. CONCLUSIONS: Our study represents the largest, most recent analysis of the efficacy and safety of IORT in patients with relapsed or refractory NB. Less than one-third of patients failed locally at 5 years, and achieving local control affected overall survival. Minimal toxicities directly related to IORT were observed. Overall, IORT is an effective and safe technique to achieve local control in high-risk relapsed or refractory neuroblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Miami Miller School of Medicine, Miami, Florida. Electronic address: bxc661@miami.edu.
- Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
- Department of Pediatrics, Neuroblastoma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Förderung
- NCI NIH HHS
- National Comprehensive Cancer Network
Zitieren
APA
Conte, B., Casey, D. L., Tringale, K. R., Honeyman, J., Narayan, N. J. C., LaQuaglia, M. P., Gerstle, J. T., Modak, S., Kushner, B. H., Kramer, K., & Wolden, S. L. (2024). Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2023.12.008
Vancouver
Conte B, Casey DL, Tringale KR, Honeyman J, Narayan NJC, LaQuaglia MP, et al. Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience. Practical Radiation Oncology. 2024. doi:10.1016/j.prro.2023.12.008
BibTeX
@article{Conte2024,
author = {Conte, Brianna and Casey, Dana L and Tringale, Kathryn R and Honeyman, Joshua and Narayan, Nicole J C and LaQuaglia, Michael P and Gerstle, Justin Ted and Modak, Shakeel and Kushner, Brian H and Kramer, Kim and Wolden, Suzanne L},
title = {Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience},
journal = {Practical Radiation Oncology},
year = {2024},
doi = {10.1016/j.prro.2023.12.008}
}
EUVIMED